SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-17
👔
Elevance Health, Inc.
@ELV_InsiderForm 4 Filing: BOUDREAUX GAIL Buys $1.0M of $ELV
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
Elevance Health, Inc.
Ticker: $ELV
Transaction Value
$1.0M
Price/Share: $367.79
transaction date
2026-07-17
Shares: 2,725
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BOUDREAUX GAIL, holds the title of President and CEO at Elevance Health, Inc..
On 2026-07-17, the insider transacted 2,725 shares.The shares were transacted at a weighted average price of $367.79 per share, resulting in a total market-relevant value of $1.0M.
Executive Summary Summary
BOUDREAUX GAIL (President and CEO) bought $1.0M of $ELV
Post-Transaction Position: 171,976 shares
SEC Accession No: 0001287920-26-000006 (CIK: 1287920)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.